Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1.68p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.25p
  • 52 Week Low: 1.23p
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 84,491
  • Market Cap: £2.22m
  • RiskGrade: 435

Latest ShareCast News

ValiRx subsidiary makes first sale

By Josh White

Date: Monday 18 Nov 2024

(Sharecast News) - ValiRx, a life science company focussed on early-stage cancer therapeutics and women's health, announced the first sale from its wholly-owned subsidiary Inaphaea BioLabs on Monday.

Valirx ShareCast News

ValiRx losses narrow in first half 27-Sep-2024 ShareCast
ValiRx pulls out of University of Barcelona coll... 26-Sep-2024 ShareCast
ValiRx subsidiary inks agreement with research f... 18-Sep-2024 ShareCast
ValiRx inks deal with Dundee Drug Discovery Unit 12-Feb-2024 ShareCast
ValiRx enters option deal with Ambrose Healthcare 05-Dec-2023 ShareCast

Valirx Regulatory News

Update on proposed sub-license of VAL401 20-Nov-2024 07:00 RNS
Contract Award 19-Nov-2024 07:00 RNS
First Sale of New Product Line 18-Nov-2024 07:00 RNS
Update on proposed sub-license of VAL201 30-Oct-2024 07:00 RNS
Directorate Change 18-Oct-2024 07:00 RNS

Valirx Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Valirx Tips & Analysis

IOS acquires Indian restaurants owner 30-Jan-2008 Times
Small caps 13-Nov-2007 Times
Kelda springs to life as takeover talk bubbles up 11-Sep-2007 Telegraph
Kelda climbs on revived takeover speculation 11-Sep-2007 The Independent
Alliance & Leicester buoyed by talk of NAB bid 09-Aug-2007 The Independent

Valirx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 1.68p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.25p
52 Week Low 1.23p
Volume 84,491
Shares Issued 132.35m
Market Cap £2.22m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.77% above the market average11.77% above the market average11.77% above the market average11.77% above the market average11.77% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Price Trend
92.05% below the market average92.05% below the market average92.05% below the market average92.05% below the market average92.05% below the market average
87.76% below the sector average87.76% below the sector average87.76% below the sector average87.76% below the sector average87.76% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:26 3,649 @ 1.67p
15:50 17,126 @ 1.60p
13:42 1,000 @ 1.60p
11:51 50,000 @ 1.68p
11:46 11,414 @ 1.60p

Valirx Key Personnel

CFO Gerald Desler

Top of Page